Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
142,480,404
-
Share change
-
+1,629,679
-
Total reported value
-
$7,209,128,718
-
Put/Call ratio
-
53%
-
Price per share
-
$50.59
-
Number of holders
-
360
-
Value change
-
+$87,362,106
-
Number of buys
-
172
-
Number of sells
-
142
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2023
As of 31 Dec 2023,
IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by
360 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
142,480,404 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BlackRock Inc., Bellevue Group AG, Clearbridge Investments, LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and Pictet Asset Management Holding SA.
This page lists
360
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.